Metropolis Healthcare Limited
NSE:METROPOLIS.NS
2115.45 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12,077.088 | 11,482.102 | 12,283.213 | 9,977.895 | 8,558.483 | 7,600.559 | 6,435.67 | 5,447.24 | 4,754.69 | 4,554.97 | 3,882.53 |
| Cost of Revenue
| 6,263.97 | 2,598.349 | 2,875.155 | 2,602.109 | 2,135.006 | 1,814.73 | 1,536.28 | 1,402.59 | 1,293.22 | 1,354.1 | 1,175.64 |
| Gross Profit
| 5,813.118 | 8,883.753 | 9,408.058 | 7,375.786 | 6,423.477 | 5,785.829 | 4,899.39 | 4,044.65 | 3,461.47 | 3,200.87 | 2,706.89 |
| Gross Profit Ratio
| 0.481 | 0.774 | 0.766 | 0.739 | 0.751 | 0.761 | 0.761 | 0.743 | 0.728 | 0.703 | 0.697 |
| Reseach & Development Expenses
| 135.768 | 87.445 | 89.079 | 68.308 | 80.924 | 69.797 | 65.245 | 41.1 | 43.4 | 51.26 | 56.86 |
| General & Administrative Expenses
| 3,604.303 | 1,324.385 | 840.582 | 419.771 | 373.721 | 357.751 | 381.65 | 313.12 | 293.21 | 0 | 0 |
| Selling & Marketing Expenses
| 327.738 | 261.555 | 257.208 | 131.251 | 112.628 | 143.493 | 123.36 | 80.25 | 87.86 | 0 | 0 |
| SG&A
| 3,932.041 | 1,585.94 | 1,097.79 | 551.022 | 486.349 | 501.244 | 505.01 | 393.37 | 381.07 | 1,180.72 | 932.47 |
| Other Expenses
| 91.17 | 152.246 | 4.354 | 20.095 | 10.008 | 2.358 | 5.68 | 11.27 | 5.66 | 0 | 0 |
| Operating Expenses
| 3,932.041 | 6,892.95 | 6,495.739 | 4,911.718 | 4,650.434 | 3,929.641 | 3,277 | 2,658.01 | 2,334.1 | 2,201.85 | 1,753.72 |
| Operating Income
| 1,881.077 | 2,143.049 | 2,795.686 | 2,464.068 | 1,773.043 | 1,856.188 | 1,622.39 | 1,386.64 | 1,127.37 | 975.92 | 907.76 |
| Operating Income Ratio
| 0.156 | 0.187 | 0.228 | 0.247 | 0.207 | 0.244 | 0.252 | 0.255 | 0.237 | 0.214 | 0.234 |
| Total Other Income Expenses Net
| -134.188 | -268.015 | 137.825 | -20.838 | -85.712 | 9.33 | -19.38 | 212.57 | 147.85 | 34.79 | 41.64 |
| Income Before Tax
| 1,746.889 | 1,875.034 | 2,933.511 | 2,443.23 | 1,687.331 | 1,865.518 | 1,603.01 | 1,599.21 | 1,275.22 | 1,010.71 | 949.4 |
| Income Before Tax Ratio
| 0.145 | 0.163 | 0.239 | 0.245 | 0.197 | 0.245 | 0.249 | 0.294 | 0.268 | 0.222 | 0.245 |
| Income Tax Expense
| 462.333 | 441.094 | 786.65 | 609.743 | 411.809 | 629.39 | 505.54 | 526.64 | 455.67 | 331.24 | 323.16 |
| Net Income
| 1,278.162 | 1,428.826 | 2,141.821 | 1,830.951 | 1,273.256 | 1,201.479 | 1,022.67 | 1,016.57 | 767.96 | 609.75 | 565.58 |
| Net Income Ratio
| 0.106 | 0.124 | 0.174 | 0.184 | 0.149 | 0.158 | 0.159 | 0.187 | 0.162 | 0.134 | 0.146 |
| EPS
| 24.95 | 27.91 | 41.87 | 35.97 | 25.36 | 24.06 | 20.61 | 20.48 | 15.25 | 11.89 | 11.03 |
| EPS Diluted
| 24.87 | 27.81 | 41.66 | 35.79 | 25.25 | 24.02 | 20.49 | 20.35 | 15.14 | 11.89 | 11.03 |
| EBITDA
| 2,825.755 | 3,035.205 | 3,600.444 | 2,976.051 | 2,194.092 | 2,055.373 | 1,803.65 | 1,646.74 | 1,347.33 | 1,174.1 | 1,066.64 |
| EBITDA Ratio
| 0.234 | 0.264 | 0.293 | 0.298 | 0.256 | 0.27 | 0.28 | 0.302 | 0.283 | 0.258 | 0.275 |